Zobrazeno 1 - 10
of 176
pro vyhledávání: '"B. Lagadec"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
B. Lagadec, Jean Cady, Marcel Krulik, S. Delfau, B. Demuynck, D. Gallot, M. Malafosse, Alain Sezeur, C. Varette, Loïc Marpeau, A. Pigne, Christophe Louvet, Barrat J, Jean-Yves Couturier, Aimery de Gramont
Publikováno v:
European Journal of Cancer. 28:53-58
40 patients with advanced ovarian cancer were treated with immediate debulking followed by sequential cisplatin and doxorubicin every 4 weeks, followed by second-look laparotomy (SLL). Six courses were given when residual disease (RD) was under 2 cm.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b6a73e2f9ba892ad192825766fbd5fa4
https://doi.org/10.1016/0959-8049(92)90384-e
https://doi.org/10.1016/0959-8049(92)90384-e
Autor:
B. Lagadec, Christian Barat
Publikováno v:
ICASSP
In this paper we propose a modified version of the classical explicit snake (active contour) approach for the segmentation of irregular object shape in video images. In the classical approach the external evolution force is computed using the gradien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9735207e6a244fced5ab231e3f5281a6
https://doi.org/10.1109/icassp.2008.4517710
https://doi.org/10.1109/icassp.2008.4517710
Autor:
A, de Gramont, A, Pigné, C, Louvet, A, Sezeur, L, Marpeau, J C, Vaillant, J, Cady, C, Varette, B, Demuynck, J Y, Couturier, B, Lagadec, J, Milliez, J, Barrat, M, Krulik
Publikováno v:
Annales de chirurgie. 51(10)
The main prognostic factor in advanced ovarian cancer is the volume of residual disease after the initial laparotomy. Early debulking surgery after several cycles of chemotherapy, before the emergence of resistant cell lines, could improve the progno
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b9f2ba73c4ddbd27e591cb6535ec8f3a
https://pubmed.ncbi.nlm.nih.gov/10868028
https://pubmed.ncbi.nlm.nih.gov/10868028
Autor:
A, de Gramont, B, Demuynck, C, Varette, C, Louvet, A, Pigne, L, Marpeau, B, Lagadec, J, Cady, J Y, Couturier, S, Delfau
Publikováno v:
European journal of cancer (Oxford, England : 1990). 28(1)
40 patients with advanced ovarian cancer were treated with immediate debulking followed by sequential cisplatin and doxorubicin every 4 weeks, followed by second-look laparotomy (SLL). Six courses were given when residual disease (RD) was under 2 cm.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::fb2e939a38b636657658c2ae4aa9fdc0
https://pubmed.ncbi.nlm.nih.gov/1567692
https://pubmed.ncbi.nlm.nih.gov/1567692
Autor:
A, de Gramont, L, Marpeau, B, Demuynck, G, Gonzalez-Canali, A, Pigné, P, Herbulot, B, Lagadec, J, Cady, J Y, Couturier, S, Delfau
Publikováno v:
Journal de gynecologie, obstetrique et biologie de la reproduction. 20(3)
Intraperitoneal chemotherapy with a totally implantable catheter was performed in 42 patients with advanced ovarian cancer who received 178 courses of chemotherapy administered in 2 l of solution. Major complication was inflow obstruction due to fibr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::28eb9793e6c329b6ebbca037cac5ac35
https://pubmed.ncbi.nlm.nih.gov/1869783
https://pubmed.ncbi.nlm.nih.gov/1869783
Autor:
A, de Gramont, L, Marpeau, B, Demuynck, C, Louvet, C, Varette, G, Gonzalez-Canali, A, Pigné, P, Herbulot, B, Lagadec, J, Cady
Publikováno v:
Journal de gynecologie, obstetrique et biologie de la reproduction. 20(3)
We studied a series of 42 patients with advanced ovarian cancer who received intraperitoneal chemotherapy post second-look laparotomy. High-dose cisplatin (200 mg/m2) alone or in combination with cytarabine (2 g) achieved 47% response rate. Median ov
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::eb5692b3f4951ce75e5103d1ec725ebf
https://pubmed.ncbi.nlm.nih.gov/1869784
https://pubmed.ncbi.nlm.nih.gov/1869784
Autor:
J.E. Maisani, S. Delfau, Marcel Krulik, B. Demuynck, A. de Gramont, C. Louvet, C. Varette, B. Lagadec, G. Gonzalez-Canali, Bernard Nordlinger
Publikováno v:
Annals of Oncology. 2:229-230
Twenty-five patients with advanced measurable gastric cancer were treated with high-dose folinic acid (200 mg/m2), 5-fluorouracil bolus (400 mg/m2) and continuous infusion (600 mg/m2) for two consecutive days every two weeks. Fourteen patients over 6
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::56554bc73532c1f87edae0ee18f065cc
https://doi.org/10.1093/oxfordjournals.annonc.a057914
https://doi.org/10.1093/oxfordjournals.annonc.a057914
Autor:
A. de Gramont, B. Lagadec, Ch. Varette, Marcel Krulik, S. Delfau, J.P. Loiseau, Jean Cady, M. Bennamoun, C. Louvet, J.E. Maisani, J. Seroka, B. Demuynck, Jean-Didier Grangé, K. Beerblock
Publikováno v:
La Revue de Médecine Interne. 13:S323
Hydroxyurea inhibits lowers the dUMP pool while increase of dUMP is a mechanism of resistance to 5FU. 71 metastatic colorectal cancer patients were treated with hydroxyure a, folinic neid and 5FU. Hydroxyurea can sometimes restore 5FU antitumoral act
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a06adda7ae7f76cd24712fd148a8e3b7
https://doi.org/10.1016/s0248-8663(05)80910-5
https://doi.org/10.1016/s0248-8663(05)80910-5
Autor:
J.E. Maisani, B. Demuynck, Jean Cady, Jean-Didier Grange, Jacques Debray, Jean-Philippe Loiseau, Jacques Seroka, B. Lagadec, Marcel Krulik, Christophe Louvet, Dray C, G. Gonzalez-Canali, Aimery de Gramont
Publikováno v:
European Journal of Cancer and Clinical Oncology. 24:1499-1503
An enhanced antineoplastic effect of 5-fluorouracil in patients with advanced colorectal cancer has been produced either by combination with folinic acid or administration by continuous infusion. Thirty-seven patients with advanced measurable colorec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0142d106951b90ffe207a8634c5b4776
https://doi.org/10.1016/0277-5379(88)90341-0
https://doi.org/10.1016/0277-5379(88)90341-0